Atossa Therapeutics
ATOS
#10645
Rank
โ‚ฌ21.72 M
Marketcap
2,18ย โ‚ฌ
Share price
-1.93%
Change (1 day)
235.38%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -โ‚ฌ32.15 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ29.8 Million a decrease over its 2024 earnings that were of -โ‚ฌ21.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ32.15 Million7.88%
2025 -โ‚ฌ29.8 Million36.33%
2024 -โ‚ฌ21.86 Million-15.25%
2023 -โ‚ฌ25.8 Million11.62%
2022 -โ‚ฌ23.11 Million30.84%
2021 -โ‚ฌ17.66 Million15.58%
2020 -โ‚ฌ15.28 Million3.41%
2019 -โ‚ฌ14.78 Million51.16%
2018 -โ‚ฌ9.78 Million40.41%
2017 -โ‚ฌ6.97 Million27.54%
2016 -โ‚ฌ5.46 Million-47.49%
2015 -โ‚ฌ10.4 Million-17.25%
2014 -โ‚ฌ12.57 Million35.91%
2013 -โ‚ฌ9.25 Million112.3%
2012 -โ‚ฌ4.36 Million46.53%
2011 -โ‚ฌ2.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.26 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.17 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ1.17 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ35.72 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚ฌ85.24 Million 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚ฌ6.72 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA